Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Technische Universität Dresden

Clinical trials sponsored by Technische Universität Dresden, explained in plain language.

Trials to join now! 11 Not yet recruiting 4 Not yet finished but already full! 1 Completed 2

Immunotherapy plus chemo shows promise for rare lung cancer

Disease control Ongoing

This phase II trial is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy (platinum and etoposide) can help people with advanced large-cell neuroendocrine lung cancer live longer. About 67 participants who have not had prior systemic treatment wil…

Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC